ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,052Medicare Part D Prescriptions Filled, Including Refills

Rank: 52 out of 1802

$751K Total Retail Price of All Prescriptions

Rank: 20 out of 1802

425 Patients Receiving at Least One Drug in Part D
58%Patients 65 Years and Older
61% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Wisconsin
Lower avg

Schedule Two
Controlled Substances

21% of this provider’s 425 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

23% of this provider’s 425 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

2% of this provider’s 5,521 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$68 was the average price of a prescription from this provider, compared to $54 among peers.

Prescriptions per Patient

26 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Wisconsin
HYDROCODONE-ACETAMINOPHEN 594 264 S3 1 10
OMEPRAZOLE 338 158 2 4
SIMVASTATIN 327 133 3 1
LEVOTHYROXINE SODIUM 325 128 4 2
AMLODIPINE BESYLATE 288 163 5 6
OXYCODONE HCL-ACETAMINOPHEN 256 63 S2 6 96
ZOLPIDEM TARTRATE 245 105 7 27
LISINOPRIL 227 108 8 3
METFORMIN HCL 194 159 9 11
PREDNISONE 176 111 10 33
TRAMADOL HCL 167 98 11 22
FUROSEMIDE 166 116 12 5
POTASSIUM CHLORIDE 158 99 13 15
TAMSULOSIN HCL 146 98 14 28
WARFARIN SODIUM 141 61 15 7
GABAPENTIN 138 54 16 16
ADVAIR DISKUS 135 70 17 32
ATORVASTATIN CALCIUM 124 73 18 14
AZITHROMYCIN 123 61 19 65
METOPROLOL TARTRATE 119 69 20 9
ROPINIROLE HCL 105 34 21 89
NEXIUM 102 26 22 50
SERTRALINE HCL 101 25 23 20
AMLODIPINE BESYLATE-BENAZEPRIL 96 78 24 116
LOSARTAN POTASSIUM 95 73 25 18
GLYBURIDE 91 64 R 26 68
PROAIR HFA 90 32 27 58
METOPROLOL SUCCINATE 85 75 28 13
CLONIDINE HCL 84 19 29 77
SPIRIVA 77 40 30 72
MIRTAZAPINE 76 27 31 38
CLOPIDOGREL 75 60 32 48
CARVEDILOL 74 41 33 36
ENALAPRIL MALEATE 73 42 34 40
RANITIDINE HCL 72 23 35 30
POLYETHYLENE GLYCOL 3350 72 16 35 29
DONEPEZIL HCL 70 68 37 26
TRIAMTERENE-HCTZ 69 48 38 49
RISPERIDONE 68 19 39 64
TRAZODONE HCL 65 0 40 39
PANTOPRAZOLE SODIUM 65 43 40 44
ALLOPURINOL 63 32 42 24
ATENOLOL 63 22 42 12
AMOX TR-POTASSIUM CLAVULANATE 62 29 44 178
CYMBALTA 60 18 45 75
PEN NEEDLE 60 29 45 124
GENERLAC 60 24 45 205
LYRICA 58 14 48 107
LIDODERM 58 34 48 92
CARISOPRODOL 57 0 R 50 191
CYCLOBENZAPRINE HCL 57 16 R 50 69
TRIAMCINOLONE ACETONIDE 56 32 52 91
FENTANYL 56 14 S2 52 43
OXYCODONE HCL 53 14 S2 54 41
LIPITOR 52 33 55 147
HYDROCHLOROTHIAZIDE 51 36 56 8
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 9, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.